About Aratana
Aratana is a Healthcare company based in United States founded in 2010, and was acquired by Elanco in April 2019. Therapeutics to treat osteoarthritis, inappetence, cancer, viral infections in pets. Aratana has raised $47 million across 6 funding rounds from investors including Elanco, Square 1 Bank and Oxford Finance. Aratana has completed 2 acquisitions, including Okapi Sciences and Vet Therapeutics. Its focus areas include Veterinary Healthcare Providers.
Company details
Aratana Therapeutics was founded in 2010 in the United States as a developer of therapeutics for companion animals. Drugs in development stages are targeted at alleviating pain and inflammation from osteoarthritis in dogs and cats. Additional medicines are being created to address inappetence, cancer, and viral infections. Operations focus on advancing these treatments within the pet healthcare sector.
- Headquarters United States
- Stage Acquired
- SectorsHealthcare
- Website aratana.com
- Acquired by Elanco (Apr 2019)
- Total Equity Funding$47M (USD)
in 6 rounds
- Latest Funding Round$40M (USD), Debt – Conventional
Oct 2015
- InvestorsElanco
& 8 more
- Investments & AcquisitionsOkapi Sciences
& 1 more
- Acquired byElanco
(Apr 2019)
Funding Insights of Aratana
Aratana has successfully raised a total of $47M across 6 strategic funding rounds. The most recent funding activity was a Debt β Conventional round of $40 million completed in October 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $47M
- Total Rounds 6
- Last Round Debt – Conventional β $40M
- First Round $20M
(Jan 2011)
- Investors Count 8
All 6 funding rounds of Aratana with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2015 | $40M | Debt – Conventional | β | β | |
| May 2015 | $56,000 | Grant | β | β | |
| Oct 2013 | $29.75M | Post-IPO | β | β | β |
| Jan 2013 | $12M | Series C | β | β | β |
| Dec 2011 | $15M | Series B | β | Kauffman Foundation, Cultivian Sandbox | |
| Jan 2011 | $20M | Series A | β | MPM Capital, Kansas Bioscience Authority | β |
9 investors in total: 9 institutional.
Investors in Aratana
Aratana has secured backing from 9 investors, including institutional and venture fund investors. Prominent investors backing the company include Elanco, Square 1 Bank and Oxford Finance.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture debt firm focused on the life sciences sector | 2002 | oxfordfinance.com | Alexandria, United States | |
| cultiviansbx.com | ||||
| avalonbioventures.com | ||||
| kansasbioauthority.org | ||||
Venture debt, treasury, and cash management services are provided. | 2005 | square1bank.com | Durham, United States | |
Invests in biotech firms developing life-saving drugs and technologies. | mpmcapital.com | |||
Funding is provided for education, workforce, and entrepreneurship initiatives. | 1966 | kauffman.org | Kansas City, United States | |
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Veterinary food and medicines products are provided for animal health. | 1954 | elanco.com | Greenfield, United States |
Investor details for Aratana
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Aratana
Aratana has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Okapi Sciences and Vet Therapeutics.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Limited information available | okapi-sciences.com | Leuven, Belgium | 2007 | Jan 2014 | $44M | |
Antibody-based therapies for companion animal cancer treatment are developed. | vettherapeutics.com | Del Mar, United States | 2009 | Oct 2013 | $30M |
Complete acquisition details for Aratana
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Aratana
7 dated milestones of Aratana across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Aratana is founded.
- Funding First funding round of $20.0M.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Vet Therapeutics.
- Acquisition Acquires Okapi Sciences.
- Funding Latest funding round, Debt β Conventional, of $40.0M.
- Exit Acquired by Elanco.
Top companies in Veterinary Healthcare & Products
3 companies that operate in the same segment as Aratana (Veterinary Healthcare & Products) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
A chain of veterinary hospitals is operated nationwide. | 1986 | Los Angeles, California, United States | USD 5.96 B | 29,000 | ||
Chain of veterinary hospital | 2012 | Westport, United States | ||||
Diagnostics and pharmaceuticals for companion animals are developed. | 2015 | Ann Arbor, Michigan, United States | USD 32.03 M | 152 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Aratana
Aratana was founded in 2010 and raised its 1st funding round 1 year after it was founded.
Aratana is headquartered in United States.
Aratana is a funded company, having raised a total of $47M across 6 funding rounds to date. The company's 1st funding round was a Series A of $20M, raised on Jan 2011.
Aratana Therapeutics was founded in 2010 in the United States as a developer of therapeutics for companion animals. Drugs in development stages are targeted at alleviating pain and inflammation from osteoarthritis in dogs and cats. Additional medicines are being created to address inappetence, cancer, and viral infections. Operations focus on advancing these treatments within the pet healthcare sector.
Aratana has made 2 acquisitions, including Okapi Sciences, and Vet Therapeutics.
Aratana has 9 investors. Key investors include Elanco, Square 1 Bank, Oxford Finance, European Union, and Kauffman Foundation.
Yes. Aratana was acquired by Elanco in April 2019.
